power producers, agri-industrial facilities, cellulosic biofuel companies, individual growers, and grower cooperatives. Research and Development Programs For the fiscal year ended August 31, 2014, the company invested $14.2 million on research and development, with the main emphasis on breeding and traits. Intellectual Property As of November 7, 2014, the company owned or had exclusive licensed rights to approximately 93 issued patents and approximately 87 pending patent applications in the United States and in various foreign jurisdictions. The patents for Ceres-developed inventions are set to expire beginning in 2020. The company’s patents or patent applications generally relate to compositions of matter for DNA and protein sequences, plants and plant parts, methods of improving plants and seed products. In addition, the company holds various granted rights or pending applications for patents and Plant Variety Protection certificates for its commercial varieties, hybrids and inbreds, as well as for methods for the improvement, production, and use of various crops. The company’s filings in foreign jurisdictions, such as Europe and Brazil are generally targeted to the products it plans to offer in those respective markets. The company continues to file new patent applications, for which terms generally extend 20 years from the filing date in the United States. Its registered and pending trademarks in the United States and in selected foreign countries include Ceres, Blade, Persephone, and Skyscraper. Significant Customers For the fiscal year ended August 31, 2014, United States Agency for International Development; Advanced Research Project Agency for Energy, Exelus; and Syngenta Biotechnology, Inc. represented 41.9%, 17.5%, 16.5% and 11.6% of the company’s revenues, respectively. Research Collaborations The company has an agreement with The Texas A&M University System for the development and commercialization of high biomass sorghum, sweet sorghum and selected related crops as energy crops, together with the discovery of molecular markers for certain traits. The company has an agreement with the Samuel Roberts Noble Foundation, Inc., a non-profit agricultural institute, for the development and commercialization of switchgrass. This relationship provides the company access to extensive breeding infrastructure and exclusive licenses to elite switchgrass varieties, breeding lines and advanced cultivars. The company has an agreement with Institute of Biological, Environmental and Rural Sciences of Aberystwyth University for morphological characterization, genetic evaluation, and the development and commercialization of miscanthus species as an energy crop. The company has a research and development collaboration with Monsanto Company focused on applying genomics technologies to identify genes that provide improvements in corn, soybean and certain other row crops. Regulatory Matters Under the Plant Protection Act of 2000, regulatory approval is required before the introduction, including the environmental release, interstate movement, and importation, of certain genetically engineered organisms, which encompasses many of the company’s biotechnology products. The primary U.S. regulatory agency overseeing field testing and deregulation for commercialization of its biotechnology products is the United States Department of Agriculture. In Brazil, the approval of biotechnology products is regulated by the National Technical Commission of Biosafety, Comissao Tecnica Nacional de Biosseguranca, or CTNBio, under the Ministry of Science and Technology. The application process for approval of a biotechnology product is generally an iterative process with the applicant providing data for review and consideration as requested by CTNBio. History Ceres, Inc. was founded in 1996. The company was incorporated in Delaware in 1996.
ceres inc (CERE:NASDAQ CM)
1535 Rancho Conejo Boulevard
Thousand Oaks, CA 91320
|Advanta Ltd||566.45 INR||+6.05|
|Illumina Inc||$198.11 USD||+4.98|
|KWS Saat SE||€288.76 EUR||+2.49|
|Syngenta AG||SFr.326.90 CHF||-5.10|
|Viaspace Inc||$0.0040 USD||-0.001|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact CERES INC, please visit www.ceres.net. Company data is provided by Capital IQ. Please use this form to report any data issues.